Skip to main content

Sidebar

Main Menu

Home
Highlights
Research
Press Releases
News Reports
Press Room
Staff Awards

Quicklinks

NUS Home
Email
Library
Student
Staff
Alumni

NUS Home
Email
Library
Student
Staff
Alumni

Home
Highlights
Research
Press Releases
News Reports
Press Room
Staff Awards

twitter share quote

08

June

2022

|

17:18

Asia/Singapore

NUS and Xiamen University develop nanovaccine to eliminate cancer tumours and inhibit recurrence

Lianhe Zaobao, 8 June 2022, p6

Newsroom

Share this page

NUS and Xiamen University develop nanovaccine to eliminate cancer tumours and inhibit recurrence

Share on: Twitter

Share on: Facebook

Share on: LinkedIn

Follow us on

Visit our Facebook page (opens in new window)
Follow us on X (opens in new window)
(opens in new window)
Visit our LinkedIn page (opens in new window)
Visit our Youtube profile (opens in new window)
(opens in new window)
(opens in new window)

Latest news

18

Apr

2024

-

Waiting for the big reward: Children who are better in delaying gratification more likely to do well academically and have fewer behavioural problems

17

Apr

2024

-

Two new courses at Residential College 4 tackle ageism through co-creation of intergenerational bonding activities

16

Apr

2024

-

When brands sue people for posting bad reviews

16

Apr

2024

-

Clones, drones and visual culture: Teaching the human condition in the 21st century

15

Apr

2024

-

S’pore joins in deep sea exploration to shed light on marine biodiversity

15

Apr

2024

-

NUS study: Chronic poor dietary habits may increase the risk of cancer

National University of Singapore

21 Lower Kent Ridge Road
Singapore 119077
+65 6516 6666

© National University of Singapore. All Rights Reserved.

Legal
Branding guidelines
Contact us
中文

Privacy Notice

This site uses cookies. By clicking accept or continuing to use this site, you agree to our use of cookies. For more details about cookies and how to manage them, please see our Privacy Notice.